PD-L1 (Programmed Death Ligand 1) Regulates T-Cell Differentiation to Control Adaptive Venous Remodeling

CONCLUSIONS: Regulation of PD-L1 activity may be a potential therapeutic target for clinical translation to improve AVF maturation.PMID:34670406 | DOI:10.1161/ATVBAHA.121.316380

Source: Arteriosclerosis, Thrombosis and Vascular Biology - October 21, 2021 Category: Cardiology Authors: Yutaka Matsubara Luis Gonzalez Gathe Kiwan Jia Liu John Langford Mingjie Gao Xixiang Gao Ryosuke Taniguchi Bogdan Yatsula Tadashi Furuyama Takuya Matsumoto Kimihiro Komori Masaki Mori Alan Dardik Source Type: research